Ra Pharmaceuticals
Cambridge
About Ra Pharmaceuticals
Ra Pharma is developing Cyclomimetics, a new drug class with the diversity and specificity of antibodies, coupled with the many benefits of small molecules. Ra Pharma is leveraging its ability to rapidly generate drug candidates to develop its own portfolio of products and partnerships focused on intracellular protein-protein interactions and other innovative approaches to addressing unmet medical needs. It was founded in 2008 and headquartered in Cambridge, Massachusetts.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 51 – 100
- Estimated revenue: $1M – $10M
- Total funding: $226.9M
- Funding stage: M&A
- Last round: Post-IPO Equity (Jul 2019)
- Ticker: nasdaq:RARX
- Website: rapharma.com
- Phone: 617-401-4060
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/ra-pharmaceuticals-215896 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.